3rd Quarter - Report
GENOMIC HEALTH for GENOMIC HEALTH
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2014 | $160,000 | Replaced |
| 3rd Quarter - Termination | Nov 14, 2014 | $160,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reimbursement of Lab Tests, Coverage of Lab Tests, FDA Regulation of Lab Tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA BERGMAN | 1999-2001 Asst to S. Michael Crapo |
| PAUL RADENSKY | — |
| DANIELLE SCELFO | — |
| SHEILA WALCOFF | 2006 HHS Counsel to Secretary Leavitt, 2004-2006 FDA Counsel |
| ERIC ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.